Hemifacial Spasm clinical trials
The registry lists 23 studies for Hemifacial Spasm across 9 countries. 3 are recruiting or about to start. 15 of them are mainly about Hemifacial Spasm (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-17.
Get an email when these change. Save the Hemifacial Spasm studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Ipsen (2) · Samsung Medical Center (2) · Peking University People's Hospital (2) · Peking Union Medical College Hospital (1) · St. Joseph's Healthcare Hamilton (1) · Kyunghee University Medical Center (1) · Tongji University (1) · University of Texas Southwestern Medical Center (1)
What is being tested here
Drugs under test in Hemifacial Spasm studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Botulinum toxin type A | 1 | 2 | 5 |
| Onabotulinum toxin A | 0 | 0 | 1 |
| Zinc Supplement | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Mar 2027Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm · Montefiore Medical Center
Who these studies take
Of the 2 Hemifacial Spasm studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 1 (50%) | 1 (50%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 1 (50%) | 1 (50%) |
Across all 23 studies, recruiting or not: 39% stop at 75 or younger and 13% at 65; 13% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 23 of 23. search them.
- Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial SpasmRecruitingNCT06195241Phase 41 country
- Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular ConflictNot yet recruitingNCT071350242 countries
- Magnetic Resonance Imaging Study on Patients With Hemifacial SpasmRecruitingNCT046452771 country
- Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai PatientsCompletedNCT04589364Phase 31 country
- Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum ToxinCompletedNCT051032021 country
- Transcutaneous Electrical Acupoint Stimulation on Postoperative Dizziness in Hemifacial Spasm PatientsCompletedNCT04621578Not applicable1 country
- Clinical Study on the Efficacy of Microvascular Decompression in the Treatment of Neurogenic HypertensionStatus unknownNCT04791410
- Microvascular Decompressive Surgery for Hemifacial SpasmStatus unknownNCT04474977
- Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial SpasmCompletedNCT00276315Phase 31 country
- Post Marketing Surveillance Study of DysportCompletedNCT002104313 countries
- Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid SpasmCompletedNCT03508882Phase 4
- Effect of Acupuncture on Inflammation and Immune Function After CraniotomyCompletedNCT02761096Not applicable1 country
- Effect of Hemifacial Spasm on Intraocular Pressure MeasurementCompletedNCT03390803
- Botulinum Toxin A in the Treatment of Hemifacial SpasmStatus unknownNCT03306940Not applicable1 country
- CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar TapWithdrawnNCT01932255
- Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression SurgeryCompletedNCT01613781Not applicable1 country
- Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression SurgeryCompletedNCT01598961Not applicable1 country
- A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese PatientsCompletedNCT017284281 country
- Hemifacial Spasm and DesfluraneStatus unknownNCT01726725
- Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial SpasmStatus unknownNCT01564979Phase 21 country
- Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial SpasmStatus unknownNCT01546805Not applicable1 country
- Observe Abnormal Potential From the Offending Vessel to the Facial Muscles of HFS PatientsStatus unknownNCT012716341 country
- Movement Disorder Survey in East ChinaCompletedNCT011683881 country